Diab H, Fuquay T, Datta P, Bickel U, Thompson J, Krutsch K
Your PlexusDx provider can help assess your personal risk based on your starting dose and any gastrointestinal symptoms you develop during the first weeks of therapy
Clinics need to be prepared for emergencies, with access to epinephrine and swift medical attention
Peptide stacking is gaining much traction in the fitness and wellness communityfor good reason
Thus, despite FDA announcing the end of the GLP-1 drug shortage in March 2025 and setting May 22 as the last day when compounded versions could be sold, the large-scale production of compounded GLP-1s continues unabated
It would also be beneficial to investigate the factors that influence weight regain after discontinuing GLP-1 medications, she said